MGTX (MeiraGTx PLC) Pangali Forward P/E

Lambang korporat lan logo meiragtx.com (MGTX)

The change in the expected P/E ratio of MeiraGTx Holdings plc (MGTX) correlates with the outsourcing of production and testing to external contractors to ensure distribution flexibility. The value of 0.00 reflects the current level of this metric. Asset value growth is supported by the partnership with Sanofi and unique gene platforms, although the business remains in a cash deficit, depleting reserves on costly R&D.

MGTX - Pangali forward rega marang bathi MeiraGTx Holdings ing rentang 04.07.2022 - 18.11.2026

MeiraGTx (MGTX) - rincian metrik lan laporan keuangan

- nilai saham lan prakiraan konsensus rega:
Pambiji fundamental:MeiraGTx PLC
Sampel barang meiragtx.com

For MeiraGTx Holdings plc (MGTX), forward earnings valuation is critical given its high R&D expenditures and stringent FDA oversight. This indicator measures the market price of one dollar of expected net income based on current reports. By analyzing the forward P/E chart for MeiraGTx Holdings plc (MGTX), an investor can see the immediate market reaction to changes in guidance. The high volatility of the curve reflects clinical trial risks, allowing for an objective assessment of patent value amid uncertainty.

Pesaing langsung

Prakiraan rega marang bathi TEM (Tempus AI, Inc)|Qiagen Group (QGEN) - Pangali forward rega marang bathi|Rega marang bathi mangsa ngarep ionispharma.com IONS|Kapitalisasi marang proyeksi bathi Repligen Corporation (RGEN)|RNA: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CRSP (CRISPR Therapeutics Corp)|WGS: Pangali Forward P/E|Rasio prakiraan rega marang bathi Ultragenyx Corp (RARE)|BEAM (Beam Therapeutics Inc) - Pangali Forward P/E|SRPT: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Twist Bioscience Corp (TWST)|Prakiraan rega marang bathi 10x Genomics Inc TXG|Intellia Therapeutics, Inc. - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi STOK|BLFS - Rega marang bathi mangsa ngarep|Wave Life Sciences (WVE) - Prakiraan rega marang bathi|MAZE: Pangali Forward P/E|Sionna Therapeutics, Inc. (SION) - Pangali Forward P/E|Rega marang bathi mangsa ngarep Prime Medicine, Inc.|TSHA (Taysha) - Rasio kapitalisasi marang bathi mangsa ngarep|Prakiraan rega marang bathi QURE (uniQure Pharma)|Kapitalisasi marang proyeksi bathi regenxbio.com|Pangali Forward P/E SLDB (Solid Biosciences Inc)|OCGN: Rasio rega marang bathi mangsa ngarep|PACB - Rega marang bathi mangsa ngarep|Benitec (BNTC) - Prakiraan rega marang bathi|DSGN: Pangali Forward P/E|RCKT: Rasio kapitalisasi marang bathi mangsa ngarep|FDMT (4D Molecular Therapeutics, Inc.) - Pangali Forward P/E|lexeotx.com (LXEO) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E KRRO|Prakiraan rega marang bathi Editas Medicine, Inc. EDIT|Rega marang bathi mangsa ngarep silence-therapeutics.com SLN|PRQR: Rasio rega marang bathi mangsa ngarep|CDXS - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Sangamo Therapeutics, Inc. SGMO|NAUT (nautilus.bio) - Prakiraan rega marang bathi|Rasio prakiraan rega marang bathi Metagenomi, Inc. (MGX)|Prakiraan rega marang bathi DTIL|Rasio rega marang bathi mangsa ngarep GBIO (generationbio.com)|Rega marang bathi mangsa ngarep Boundless Bio, Inc (BOLD)|Pangali Forward P/E Exicure Inc. (XCUR)|Imunon, Inc. - Prakiraan rega marang bathi|PHIO: Rasio rega marang bathi mangsa ngarep|MBIO - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake RNAZ|Bionano Genomics, Inc. (BNGO) - Rega marang bathi mangsa ngarep|Applied DNA Sciences, Inc. (APDN) - Pangali Forward P/E|BLUE (bluebirdbio.com) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep IPA (ImmunoPrecise Antibodies)|Pangali Forward P/E OMGA|Prakiraan rega marang bathi Singular Genomics Systems OMIC|Pangali Forward P/E RGLS (regulusrx.com)|Syros Pharmaceuticals Inc. (SYRS) - Rasio prakiraan rega marang bathi|TBIO: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TCON (TRACON)|UBX: Pangali Forward P/E